Pre-made Miromavimab benchmark antibody ( Whole mAb (Mouse), anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-348

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-348 Category Tag

Product Details

Pre-Made Miromavimab biosimilar, Whole mAb (Mouse): Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Products Name (INN Index)

Pre-Made Miromavimab biosimilar, Whole mAb (Mouse): Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II therapeutic antibody

INN Name

Miromavimab

Target

Rabies Virus Strain ERA GP Ectodomain Epitope G-II

Format

Whole mAb (Mouse)

Derivation

NA

Species Reactivity

Human

CH1 Isotype

IgG1

VD LC

Kappa

Highest_Clin_Trial (Jan '20)

Approved

Est. Status

NFD

100% SI Structure

None

99% SI Structure

None

95-98% SI Structure

None

Year Proposed

2019

Companies

Candila Healthcare

Conditions Approved

Rabies

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

Rabies Virus Strain ERA GP Ectodomain Epitope G-II

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide